IRVINE, Calif., May 21, 2018 /PRNewswire/ -- Inari Medical, Inc., announced today the FlowTriever System has received FDA 510(k) clearance for the treatment of pulmonary embolism ("PE").

IRVINE, Calif., Nov. 02, 2022 (GLOBE NEWSWIRE) -- Inari Medical, Inc ... The decrease in gross margin is primarily due to the addition of new products to our FlowTriever per procedure ...

“PEERLESS II will build off Inari’s FLASH registry, the largest prospective registry ever conducted in PE thrombectomy evaluating the FlowTriever System in 1,000 patients,” said Dr. Thomas ...

Image Source: Zacks Investment Research Inari Medical has positioned itself as a leader in the treatment of venous ...

Inari Medical NARI continues to ride on the success of its ClotTriever and FlowTriever products available for treating venous thromboembolism (VTE). The adoption of these products is rising on the ...

Inari Medical, Inc. has several devices for venous thrombectomy like The FlowTriever and ClotTriever devices. Several ongoing clinical trials and increasing quarterly sales have the potential to ...

The physicians knew how to use Inari Medical Inc.’s FlowTriever to substantially remove a clot and she returned to a normal heart rate. “After several days of further improvement, this patient was ...

This hospital, with the assistance of Inari Medical, had developed a comprehensive PE thrombectomy program and had several physicians well versed in using the FlowTriever system. In a short 45 ...

DEFIANCE is Inari’s second RCT and it will run in parallel to the PEERLESS trial. PEERLESS began earlier this year and compares FlowTriever to catheter-directed thrombolytics in pulmonary embolism.